Form 8-K - Current report:
SEC Accession No. 0001297184-25-000036
Filing Date
2025-06-04
Accepted
2025-06-03 20:46:19
Documents
16
Period of Report
2025-06-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20250602x8k.htm   iXBRL 8-K 83212
2 EX-3.1 amph-20250602xex3d1.htm EX-3.1 10655
3 EX-3.2 amph-20250602xex3d2.htm EX-3.2 9377
4 EX-3.3 amph-20250602xex3d3.htm EX-3.3 275988
5 GRAPHIC amph-20250602xex3d3001.jpg GRAPHIC 715
  Complete submission text file 0001297184-25-000036.txt   547127

Data Files

Seq Description Document Type Size
6 EX-101.SCH amph-20250602.xsd EX-101.SCH 3499
7 EX-101.LAB amph-20250602_lab.xml EX-101.LAB 16015
8 EX-101.PRE amph-20250602_pre.xml EX-101.PRE 10822
18 EXTRACTED XBRL INSTANCE DOCUMENT amph-20250602x8k_htm.xml XML 4829
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 251021627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)